What should I do if I have liver cancer and a fever of 38 degrees Celsius?

Written by Cui Fang Bo
Oncology
Updated on November 30, 2024
00:00
00:00

Liver cancer patients experiencing a fever of 38°C can be seen in the following scenarios: The first type is tumor-related fever. In liver cancer patients, especially those in the advanced stages or with large tumors, a fever of around 38°C can occur in the absence of infection symptoms. This tumor fever is related to various mediators released into the blood by the tumor. The second type is infectious fever. Cancer patients undergoing anti-tumor treatment may experience immunosuppression and concurrent infections. This type of fever often exceeds 38.5°C but can also occur around 38°C in the early stages, often accompanied by symptoms of infection such as coughing, sputum production, abdominal pain, and diarrhea. The third type is treatment-related fever. Patients with liver cancer may experience a fever of around 38°C on the day of and several days following interventional treatments.

Other Voices

doctor image
home-news-image
Written by Zhang Lu
Obstetrics
1min 1sec home-news-image

Can alpha-fetoprotein diagnose liver cancer?

Alpha-fetoprotein, also known as AFP, reflects the function of the liver and whether there are any diseases present. The accuracy and specificity of alpha-fetoprotein in diagnosing liver cancer are relatively high. In non-pregnant individuals, whether male or female, an elevated alpha-fetoprotein level should raise suspicions of liver disease, and it is advisable to promptly undergo ultrasound or CT scans to determine the presence of liver cancer or other liver diseases. However, during pregnancy, as the fetus grows and develops, a certain amount of alpha-fetoprotein is released. Therefore, when testing the blood of pregnant women, an increase in alpha-fetoprotein is observed. This condition is a physiological change and does not indicate the occurrence of liver diseases such as liver cancer in women. Thus, alpha-fetoprotein can serve as an auxiliary method for diagnosing liver cancer, but only in non-pregnant individuals.

doctor image
home-news-image
Written by Du Ning
Hepatobiliary Surgery
1min 8sec home-news-image

Can gallbladder stones turn into liver cancer?

Long-term pathological changes from hepatobiliary calculi can lead to liver cancer. Hepatobiliary calculi generally refer to intrahepatic bile duct stones. When these stones grow in a single duct and gradually increase in number and size, they can cause obstruction of the bile duct. Obstruction of the bile duct subsequently leads to cholangitis, which involves repeated inflammatory irritation. This, in turn, can cause malignant transformation of the bile duct cells. Following this transformation, a tumor forms, which can develop into cholangiocellular carcinoma, a type of liver cancer. Therefore, if intrahepatic bile duct stones cause long-term inflammatory stimulation, it can lead to cancerous changes and result in liver cancer. Thus, if intrahepatic bile duct stones have already caused noticeable clinical symptoms such as abdominal pain, fever, and liver function abnormalities, aggressive surgical treatment should be considered.

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 1sec home-news-image

What are the symptoms on the face in the early stages of liver cancer?

In early-stage liver cancer patients, symptoms generally do not appear on their faces. This is because the tumors in early liver cancer are small, the lesions are localized, with shallow infiltration, no invasion of surrounding tissues or metastasis to distant organs, and thus, less damage to liver cells. Therefore, most cases do not show obvious symptoms clinically. Only when the lesions progress further do symptoms of disease dissemination appear in patients. These symptoms include persistent pain in the liver area, a significant decrease in appetite, fatigue, fever, and weight loss. Some patients may also experience symptoms of metastatic lesions, such as pain in bone metastases, headache, vomiting, hemiplegia, and aphasia in brain metastases, and cough, breathing difficulties, and chest pain in lung metastases.

doctor image
home-news-image
Written by Liu Liang
Oncology
59sec home-news-image

Is primary liver cancer hereditary?

The occurrence of tumors is related to multiple factors including genetics, environment, and the lifestyle habits of the patient. Therefore, primary liver cancer does have a genetic component. If parents, siblings, grandparents, etc., have a history of liver cancer, the offspring of such patients might have a higher probability of developing liver cancer compared to the general population. However, it's not absolute, as it also depends on other factors like environment, personal dietary habits, lifestyle habits, whether one has hepatitis, alcoholic liver cirrhosis, and other similar factors. Thus, those with a family history of liver cancer are likely to have a higher risk of developing the condition and should be more vigilant about disease screening. Screening should be more frequent than for the general population, but this is not an absolute rule.

doctor image
home-news-image
Written by Sun Wei
Surgical Oncology
57sec home-news-image

The difference between primary liver cancer and secondary liver cancer

Primary liver cancer, also commonly referred to as liver cancer, originates in the liver itself and is not transferred from other parts of the body. Secondary liver cancer occurs when the primary tumor originates in another location and then metastasizes to the liver, causing hepatic space-occupying lesions; this is referred to as secondary liver cancer. The main difference between the two types is their origin. Additionally, primary liver cancer is often solitary but may develop intrahepatic or distant metastases as the disease progresses. In cases of secondary liver cancer, multiple intrahepatic metastatic lesions may be discovered at the onset. Moreover, primary liver cancer may often display an elevated alpha-fetoprotein tumor marker, whereas this marker might be normal in secondary liver cancer.